AmpC β-lactamases: What do we need to know for the future?

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 1, 2003, Pages 2-4

  Hanson, Nancy D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lactamase; AmpC

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; IMIPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION;

BACTERIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; KINETICS; PLASMIDS;

EID: 0038601508     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sanders, C. C. (1987). Chromosomal cephalosporinases responsible for multiple resistance to newer β-lactam antibiotics. Annual Review of Microbiology 41, 573-93.
2. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
3. Hanson, N. D. & Sanders, C. C. (1999). Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Current Pharmaceutical Design 5, 881-94.
4. Raimondi, A., Sisto, F. & Nikaido, H. (2001). Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrobial Agents and Chemotherapy 45, 2331-9.
5. Philippon, A., Arlet, G. & Jacoby, G. A. (2002). Plasmid-determined AmpC-type β-lactamases. Antimicrobial Agents and Chemotherapy 46, 1-11.
6. Papanicolaou, G. A., Medeiros, A. A. & Jacoby, G. A. (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 34, 2200-9.
7. MOX-1 gene encoding AmpC-type β-lactamase. Gene 139, 93-8.
8. Jones, R. N. (1998). Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes. Diagnostic Microbiology and Infectious Disease 31, 461-6.
9. Minami, S., Yotsuji, A., Inoue, M. et al. (1980). Induction of β-lactamase by various β-lactam antibiotics in Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 18, 382-5.
10. Sanders, C. C. & Sanders, W. E. (1986). Type I β-lactamases of Gram-negative bacteria: interactions with β-lactam antibiotics. Journal of Infectious Diseases 154, 792-800.
11. Lindquist, S., Lindberg, F. & Normark, S. (1989). Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC β-lactamase gene. Journal of Bacteriology 171, 3746-53.
12. Lindberg, F. & Normark, S. (1987). Common mechanism of AmpC β-lactamase induction in Enterobacteria: regulation of the cloned Enterobacter cloacae P99 β-lactamase gene. Journal of Bacteriology 169, 758-63.
13. Honore, N., Nicolas, M. H. & Cole, S. T. (1986). Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO Journal 5, 3709-14.
14. Lindberg, F., Westman, L. & Normark, S. (1985). Regulatory components in Citrobacter freundii AmpC β-lactamase induction. Proceedings of the National Academy of Sciences, USA 82, 4620-4.
15. Mahlen, S. D., Morrow, S. S., Abdalhamid, B. et al. (2003). Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. Journal of Antimicrobial Chemotherapy 51, 791-802.
16. Bush, K. (2001). New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clinical Infectious Diseases 32, 1085-9.
17. Gazouli, M., Tzouvelekis, L. S., Prinarakis, E. et al. (1996). Transferable cefoxitin resistance in Enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrobial Agents and Chemotherapy 40, 1736-40.
18. Poirel, L., Guibert, M., Girlich, D. et al. (1999). Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrobial Agents and Chemotherapy 43, 769-76.
19. Reisbig, M. D., Hossain, A. & Hanson, N. D. (2003). Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. Journal of Antimicrobial Chemotherapy 51, 1141-51.
20. Barlow, M. & Hall, B. G. (2002). Origin and evolution of the AmpC β-lactamases of Citrobacter freundii. Antimicrobial Agents and Chemotherapy 46, 1190-8.
21. Coudron, P., Hanson, N. D. & Climo, M. W. (2003). Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. Journal of Clinical Microbiology 41, 772-7.
22. Medeiros, A. A. (1997). Relapsing infection due to Enterobacter species: lessons of heterogeneity. Clinical Infectious Diseases 25, 341-2.
23. McClelland, M., Sanderson, K. E., Spieth, J. et al. (2001). Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852-6.
24. Sanchez, S., McCrackin S. M. A., Hudson, C. R. et al. (2002). Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. Journal of Clinical Microbiology 40, 3586-95.
25. Winokur, P. L., Brueggemann, A., Desalvo, D. L. et al. (2000). Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrobial Agents and Chemotherapy 44, 2777-83.
26. Thomson, K. S. (2001). Controversies about extended-spectrum and AmpC β-lactamases. Emerging Infectious Diseases 7, 333-6.
27. Thomson, K. S. & Sanders, C. C. (1992). Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrobial Agents and Chemotherapy 36, 1877-82.
28. Black, J., Moland, E. S. & Thomson, K. S. (2002). A simple disk test for detection of plasmid-mediated AmpC production in Klebsiella. In Program and Abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002. Abstract D-534, p. 140. American Society for Microbiology, Washington, DC, USA.
29. Perez-Perez, F. J. & Hanson, N. D. (2002). Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 40, 2153-62.
30. Paterson, D. L., Ko, W. C., Von Gottberg, A. et al. (2001). Out-come of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. Journal of Clinical Microbiology 39, 2206-12.
31. Barnaud, G., Labia, R., Raskine, L. et al. (2001). Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiology Letters 195, 185-90.